Observational studyESC heart failure2022

Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy.

Hsin-Ti Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.